https://de.marketscreener.com/kurs/aktie/ADDEX-THERAPEUTICS-LTD-261774/news/ADDEX-PHA-schliesst-Rekrutierung-von-Patienten-mit-GERD-fur-klinische-Phase-IIb-Studie-ab-13251634/?utm_source=telegram&utm_medium=social&utm_campaign=share